This trial is a critical step to uncovering an effective way to alleviate the seizure burden in this population of children with a rare, difficult-to-treat disease.
FOUR20 owns and operates six stores in Alberta and has secured 16 additional high-traffic store locations
Agreement is for up to C$110M subject to the achievement of performance milestones by FOUR20
NYU School of Medicine will lead trials testing CBD treatment for patients with Alcohol Use Disorder and Post-Traumatic Stress Disorder with Alcohol Use Disorder
Additional 20 hectares of outdoor growing space increases company’s capacity to supply medical cannabis across Europe and to other international markets
Ireland becomes the 13th country with Tilray medical cannabis products as company continues global expansion in Europe and increases access to patients in need